Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иван МУРГОВ, Запряна ДЕНКОВАfiledCriticalИван МУРГОВ
Priority to BG103668ApriorityCriticalpatent/BG63614B1/en
Publication of BG103668ApublicationCriticalpatent/BG103668A/en
Publication of BG63614B1publicationCriticalpatent/BG63614B1/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
The method shall be applied for the prevention and treatment of diarrhoeas, gastrointestinal infections and dysbacteriosis in humans and animals, as well as for the cholesterol level regulation and for reinforcing the immune system. The freeze-dry and standardized products are administered as preparations for direct application and as yeasts for the preparation of fermented lactic acid products of probiotic effect. By the method probiotics are produced having high titre of live active cells of mixed and symbiotic cultures of selected strains of LAB 8 lactobacilli and streptococci, registered in NBIMCC under No. 2416, Lactobacillus LBC 7, registered in NBIMCC under No, 3599, Lactobacillus LBG-MZ, registered in NBIMCC under No. 3600, Lactobacillus bulgaricus LB 51-157, registered in NBIMCC under No. 3598, Streptococcus thermophilus 35, registered in NBIMCC under no. 3597 and Bifidobacterium bifidum BB 87, registered in NBIMCC under No. 3601. 1 claim
BG103668A1999-08-181999-08-18Method for the production of probiotics
BG63614B1
(en)
CONSORTIUM OF BIFIDOBACTERIUM BIFIDOBACTERIUM BIFIDUM 791, B. LONGUM B 379 M, B. BREVE 79-119 B. INFANTIS 73-15, B. ADOLESCENTIS D 7513 FOR PREPARATION OF Dairy, non-fermented food
Optimal effect of Lactobacillus delbruecki subsp. bulgaricus, among other lactobacilli species, on the number of IgA and mast cells associated with the mucosa in immunosuppressed mice